Details of Terzepatide: Approvals and Indications: Type 2 Diabetes: Tirzepatide, marketed as Mounjaro, is approved for the treatment of type 2 diabetes. It is typically administered at doses ranging from 2.5 mg to 15 mg once weekly. Chronic Weigh ...